CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
|
Total |
Series A, Preferred Stock |
Series B, Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Stock Payable [Member] |
Retained Earnings (Accumulated Deficit) |
Noncontrolling Interest |
Balance, shares at Mar. 31, 2019 |
|
5,000,000
|
|
301,758,293
|
|
|
|
|
Balance, amount at Mar. 31, 2019 |
$ (2,856,986)
|
$ 500
|
$ 0
|
$ 30,177
|
$ 38,335,782
|
$ 0
|
$ (41,223,445)
|
$ 0
|
Issuance of shares under equity financing agreement, shares |
|
|
|
14,744,646
|
|
|
|
|
Issuance of shares under equity financing agreement, amount |
1,774,000
|
|
|
$ 1,474
|
1,772,526
|
|
|
|
Issuance of shares upon conversion, shares |
|
|
|
63,239,585
|
|
|
|
|
Issuance of shares upon conversion, amount |
639,710
|
|
|
$ 6,323
|
633,386
|
|
|
|
Reclass of derivative liability upon conversion or redemption of related convertible debentures |
8,000
|
|
|
|
8,000
|
|
|
|
Purchase of Series B Preferred shares, shares |
|
|
2,250
|
|
|
|
|
|
Purchase of Series B Preferred shares, amount |
2,250,000
|
|
$ 0
|
|
2,250,000
|
|
|
|
Beneficial conversion feature related to the Series B Preferred Shares |
0
|
|
|
|
475,000
|
|
(475,000)
|
|
Beneficial conversion feature |
58,548
|
|
|
|
58,548
|
|
|
|
Net loss |
(4,728,951)
|
|
|
|
|
|
(4,728,951)
|
(82,101)
|
Common stock issued to consultant, amount |
0
|
|
|
|
|
|
|
|
Balance, shares at Mar. 31, 2020 |
|
5,000,000
|
2,250
|
379,742,524
|
|
|
|
|
Balance, amount at Mar. 31, 2020 |
(2,937,780)
|
$ 500
|
$ 0
|
$ 37,975
|
43,533,243
|
0
|
(46,427,396)
|
(82,101)
|
Beneficial conversion feature related to the Series B Preferred Shares |
0
|
|
|
|
293,000
|
|
(293,000)
|
|
Net loss |
(478,967)
|
|
|
|
|
|
(477,072)
|
(1,895)
|
Purchase of Series B Preferred shares, shares |
|
|
1,250
|
|
|
|
|
|
Purchase of Series B Preferred shares, amount |
1,250,000
|
|
$ 0
|
|
1,250,000
|
|
|
|
Series B PS Dividends in kind issued, shares |
|
|
50
|
|
|
|
|
|
Series B PS Dividends in kind issued, amount |
56,458
|
|
$ 0
|
|
56,458
|
|
|
|
Conversion of Series B PS to common stock, shares |
|
|
(800)
|
33,569,730
|
|
|
|
|
Conversion of Series B PS to common stock, amount |
0
|
|
$ (0)
|
$ 3,357
|
(3,357)
|
|
|
|
Issuance of common stock upon conversion, shares |
|
|
|
37,926,239
|
|
|
|
|
Issuance of common stock upon conversion, amount |
226,437
|
|
|
$ 3,793
|
222,644
|
|
|
|
Common stock issued in Vista Warrant settlement, shares |
|
|
|
17,500,000
|
|
|
|
|
Common stock issued in Vista Warrant settlement, amount |
610,000
|
|
|
$ 1,750
|
608,250
|
|
|
|
Common stock issued to consultant, shares |
|
|
|
1,250,000
|
|
|
|
|
Common stock issued to consultant, amount |
61,250
|
|
|
$ 125
|
61,125
|
|
|
|
Reclass of derivative liability upon conversion or redemption of related convertible debentures, amount |
205,000
|
|
|
|
205,000
|
|
|
|
Reclass of warrant liability upon the cancellation of warrants under Vista Warrant settlement |
90,000
|
|
|
|
90,000
|
|
|
|
Dividends payable on Series B PS |
(144,792)
|
|
|
|
|
|
(144,792)
|
|
Balance, shares at Jun. 30, 2020 |
|
5,000,000
|
2,750
|
469,988,493
|
|
|
|
|
Balance, amount at Jun. 30, 2020 |
(1,062,394)
|
$ 500
|
$ 0
|
$ 47,000
|
46,316,363
|
0
|
(47,342,260)
|
(83,996)
|
Balance, shares at Mar. 31, 2020 |
|
5,000,000
|
2,250
|
379,742,524
|
|
|
|
|
Balance, amount at Mar. 31, 2020 |
(2,937,780)
|
$ 500
|
$ 0
|
$ 37,975
|
43,533,243
|
0
|
(46,427,396)
|
(82,101)
|
Net loss |
(1,065,265)
|
|
|
|
|
|
|
|
Common stock issued to consultant, amount |
128,750
|
|
|
|
|
|
|
|
Balance, shares at Sep. 30, 2020 |
|
5,000,000
|
1,696
|
531,023,743
|
|
|
|
|
Balance, amount at Sep. 30, 2020 |
(215,012)
|
$ 500
|
$ (0)
|
$ 53,103
|
48,638,480
|
0
|
(48,821,413)
|
(85,682)
|
Balance, shares at Mar. 31, 2020 |
|
5,000,000
|
2,250
|
379,742,524
|
|
|
|
|
Balance, amount at Mar. 31, 2020 |
(2,937,780)
|
$ 500
|
$ 0
|
$ 37,975
|
43,533,243
|
0
|
(46,427,396)
|
(82,101)
|
Reclass of derivative liability upon conversion or redemption of related convertible debentures |
205,000
|
|
|
|
205,000
|
|
|
|
Purchase of Series B Preferred shares, shares |
|
|
3,250
|
|
|
|
|
|
Purchase of Series B Preferred shares, amount |
3,250,000
|
|
$ 0
|
|
3,250,000
|
|
|
|
Beneficial conversion feature related to the Series B Preferred Shares |
0
|
|
|
|
1,335,000
|
|
(1,335,000)
|
|
Net loss |
(3,580,454)
|
|
|
|
|
|
(3,580,454)
|
(5,729)
|
Series B PS Dividends in kind issued, shares |
|
|
115
|
|
|
|
|
|
Series B PS Dividends in kind issued, amount |
134,442
|
|
$ 0
|
|
134,442
|
|
|
|
Conversion of Series B PS to common stock, shares |
|
|
(5,008)
|
113,517,030
|
|
|
|
|
Conversion of Series B PS to common stock, amount |
0
|
|
$ 0
|
$ 11,351
|
(11,351)
|
|
|
|
Issuance of common stock upon conversion, shares |
|
|
|
39,735,626
|
|
|
|
|
Issuance of common stock upon conversion, amount |
551,021
|
|
|
$ 3,974
|
547,047
|
|
|
|
Common stock issued in Vista Warrant settlement, shares |
|
|
|
17,500,000
|
|
|
|
|
Common stock issued in Vista Warrant settlement, amount |
610,000
|
|
|
$ 1,750
|
608,250
|
|
|
|
Common stock issued to consultant, amount |
745,250
|
|
|
|
|
|
|
|
Dividends payable on Series B PS |
(317,085)
|
|
|
|
|
|
(317,085)
|
|
Reclass of warrant liability upon the cancellation of warrants under Vista Warrant settlement |
90,000
|
|
|
|
90,000
|
|
|
|
Common stock issued to consultant, shares |
|
|
|
4,250,000
|
|
|
|
|
Common stock issued to consultant, amount |
745,250
|
|
|
$ 425
|
744,825
|
|
|
|
Beneficial conversion feature related to the Series D Preferred Shares |
6,050,000
|
|
|
|
6,050,000
|
|
|
|
Amortization of beneficial conversion feature related to Series D Preferred Shares |
(1,720,833)
|
|
|
|
|
|
(1,720,833)
|
|
Accretion on Series D Preferred shares |
(302,500)
|
|
|
|
|
|
(302,500)
|
|
Commitment shares issued with Series D Preferred Shares, shares |
|
|
|
6,000,000
|
|
|
|
|
Commitment shares issued with Series D Preferred Shares, amount |
0
|
|
|
$ 600
|
(600)
|
|
|
|
Common stock to be issued as finder's fees related to asset acquisition |
136,000
|
|
|
|
|
136,000
|
|
|
Beneficial conversion feature related to convertible debenture |
163,636
|
|
|
|
163,636
|
|
|
|
Beneficial conversion feature related to the Series E Preferred Shares |
1,721,000
|
|
|
|
|
|
|
|
Balance, shares at Mar. 31, 2021 |
|
5,000,000
|
607
|
560,745,180
|
|
|
|
|
Balance, amount at Mar. 31, 2021 |
311,604
|
$ 500
|
$ 0
|
$ 56,075
|
56,649,491
|
136,000
|
(53,683,268)
|
(87,830)
|
Balance, shares at Jun. 30, 2020 |
|
5,000,000
|
2,750
|
469,988,493
|
|
|
|
|
Balance, amount at Jun. 30, 2020 |
(1,062,394)
|
$ 500
|
$ 0
|
$ 47,000
|
46,316,363
|
0
|
(47,342,260)
|
(83,996)
|
Beneficial conversion feature related to the Series B Preferred Shares |
0
|
|
$ 0
|
|
807,000
|
|
(807,000)
|
|
Net loss |
(588,193)
|
|
|
|
|
|
(588,193)
|
(1,686)
|
Purchase of Series B Preferred shares, shares |
|
|
1,250
|
|
|
|
|
|
Purchase of Series B Preferred shares, amount |
1,250,000
|
|
$ 0
|
|
1,250,000
|
|
|
|
Series B PS Dividends in kind issued, shares |
|
|
65
|
|
|
|
|
|
Series B PS Dividends in kind issued, amount |
77,984
|
|
|
|
77,984
|
|
|
|
Conversion of Series B PS to common stock, shares |
|
|
(2,369)
|
58,521,249
|
|
|
|
|
Conversion of Series B PS to common stock, amount |
0
|
|
$ (0)
|
$ 5,852
|
(5,852)
|
|
|
|
Issuance of common stock upon conversion, shares |
|
|
|
1,014,001
|
|
|
|
|
Issuance of common stock upon conversion, amount |
125,736
|
|
|
$ 101
|
125,635
|
|
|
|
Common stock issued to consultant, shares |
|
|
|
1,500,000
|
|
|
|
|
Common stock issued to consultant, amount |
67,500
|
|
|
$ 150
|
67,350
|
|
|
|
Dividends payable on Series B PS |
(83,960)
|
|
|
|
|
|
(83,960)
|
|
Balance, shares at Sep. 30, 2020 |
|
5,000,000
|
1,696
|
531,023,743
|
|
|
|
|
Balance, amount at Sep. 30, 2020 |
(215,012)
|
$ 500
|
$ (0)
|
$ 53,103
|
48,638,480
|
0
|
(48,821,413)
|
(85,682)
|
Balance, shares at Mar. 31, 2021 |
|
5,000,000
|
607
|
560,745,180
|
|
|
|
|
Balance, amount at Mar. 31, 2021 |
311,604
|
$ 500
|
$ 0
|
$ 56,075
|
56,649,491
|
136,000
|
(53,683,268)
|
(87,830)
|
Net loss |
(2,562,743)
|
|
|
|
|
|
(2,562,743)
|
|
Conversion of Series B PS to common stock, shares |
|
|
(262)
|
3,144,000
|
|
|
|
|
Conversion of Series B PS to common stock, amount |
0
|
|
$ 0
|
$ 314
|
(314)
|
|
|
|
Issuance of common stock upon conversion, shares |
|
|
|
1,329,246
|
|
|
|
|
Issuance of common stock upon conversion, amount |
421,486
|
|
|
$ 133
|
421,353
|
|
|
|
Common stock issued to consultant, shares |
|
|
|
125,000
|
|
|
|
|
Common stock issued to consultant, amount |
73,651
|
|
|
$ 13
|
48,738
|
24,900
|
|
|
Beneficial conversion feature related to the Series E Preferred Shares |
3,269,505
|
|
|
|
3,269,505
|
|
|
|
Conversion of Series D PS to common stock, amount |
0
|
|
$ 0
|
$ 43
|
(43)
|
|
|
|
Conversion of Series D PS to common stock, shares |
|
|
|
428,572
|
|
|
|
|
Sale of common shares and warrants for cash, less offering costs and commitment shares, shares |
|
|
|
35,772,729
|
|
|
|
|
Sale of common shares and warrants for cash, less offering costs and commitment shares, amount |
17,277,123
|
|
|
$ 3,577
|
17,273,546
|
|
|
|
Exercise of warrants related to the sale of common shares, shares |
|
|
|
1,100,000
|
|
|
|
|
Exercise of warrants related to the sale of common shares, amount |
11,000
|
|
|
$ 110
|
10,890
|
|
|
|
Common shares to be issued for the acquisition of the non-controlling interest subsidiary's remaining equity |
(1,000,000)
|
|
|
|
(3,087,830)
|
2,000,000
|
|
87,830
|
Common shares to be issued for Patent acquisition |
5,000,000
|
|
|
|
|
5,000,000
|
|
|
Exchange of Series D PS to Series E PS |
(3,258,189)
|
|
|
|
|
|
(3,258,189)
|
|
Amortization of beneficial conversion feature related to Series E Preferred Shares |
(817,376)
|
|
|
|
|
|
(817,376)
|
|
Redemption of Series D Preferred shares |
(2,534,758)
|
|
|
|
|
|
(2,534,758)
|
|
Balance, shares at Jun. 30, 2021 |
|
5,000,000
|
345
|
602,644,727
|
|
|
|
|
Balance, amount at Jun. 30, 2021 |
18,950,668
|
$ 500
|
$ 0
|
$ 60,266
|
74,585,336
|
7,160,900
|
(62,856,334)
|
0
|
Balance, shares at Mar. 31, 2021 |
|
5,000,000
|
607
|
560,745,180
|
|
|
|
|
Balance, amount at Mar. 31, 2021 |
311,604
|
$ 500
|
$ 0
|
$ 56,075
|
56,649,491
|
136,000
|
(53,683,268)
|
(87,830)
|
Net loss |
(5,412,378)
|
|
|
|
|
|
|
|
Common stock issued to consultant, amount |
122,926
|
|
|
|
|
|
|
|
Balance, shares at Sep. 30, 2021 |
|
5,000,000
|
345
|
606,821,513
|
|
|
|
|
Balance, amount at Sep. 30, 2021 |
19,210,511
|
$ 500
|
$ 0
|
$ 60,683
|
74,609,294
|
11,948,176
|
(67,408,142)
|
0
|
Balance, shares at Jun. 30, 2021 |
|
5,000,000
|
345
|
602,644,727
|
|
|
|
|
Balance, amount at Jun. 30, 2021 |
18,950,668
|
$ 500
|
$ 0
|
$ 60,266
|
74,585,336
|
7,160,900
|
(62,856,334)
|
0
|
Net loss |
(2,849,635)
|
|
|
|
|
|
(2,849,635)
|
|
Common stock issued to consultant, shares |
|
|
|
62,500
|
|
|
|
|
Common stock issued to consultant, amount |
49,275
|
|
|
$ 6
|
24,369
|
24,900
|
|
|
Amortization of beneficial conversion feature related to Series E Preferred Shares |
(1,341,948)
|
|
|
|
|
|
(1,341,948)
|
|
Conversion of Series E PS to common stock, shares |
|
|
|
4,114,286
|
|
|
|
|
Conversion of Series E PS to common stock, amount |
0
|
|
|
$ 411
|
(411)
|
|
|
|
Common shares to be issued for Technical and Equipment Rights Agreement |
4,762,376
|
|
|
|
|
4,762,376
|
|
|
Revision of dividends payable on Series B Preferred Shares (See Note 2) |
|
|
|
|
|
|
(182,639)
|
|
Dividends payable on Preferred Shares |
|
|
|
|
|
|
(177,586)
|
|
Balance, shares at Sep. 30, 2021 |
|
5,000,000
|
345
|
606,821,513
|
|
|
|
|
Balance, amount at Sep. 30, 2021 |
$ 19,210,511
|
$ 500
|
$ 0
|
$ 60,683
|
$ 74,609,294
|
$ 11,948,176
|
$ (67,408,142)
|
$ 0
|